Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

enGene Holdings Inc. - Common Stock (NQ:ENGN)

9.370 -0.180 (-1.88%)
Streaming Delayed Price Updated: 11:05 AM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,391
Open 9.360
Bid (Size) 9.340 (200)
Ask (Size) 9.650 (500)
Prev. Close 9.550
Today's Range 9.240 - 9.740
52wk Range 2.650 - 12.25
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
From enGene Holdings Inc.
Via Business Wire

Performance

YTD
+5.9%
+5.9%
1 Month
+6.4%
+6.4%
3 Month
+55.9%
+55.9%
6 Month
+153.9%
+153.9%
1 Year
+47.1%
+47.1%

More News

Read More
News headline image
enGene Reports Full Year 2025 Financial Results and Provides Business Update
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene to Present at the Piper Sandler 37th Annual Healthcare Conference
From enGene Holdings Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene Announces Proposed Public Offering of Common Shares
From enGene Holdings Inc.
Via Business Wire
News headline image
Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
News headline image
Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump ↗
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga
News headline image
EnGene Encouraged By Promising Response Rates In Bladder Cancer Trial ↗
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
PubMatic Posts Upbeat Q3 Results, Joins Energy Vault, RealReal And Other Big Stocks Moving Higher On Tuesday ↗
Via Benzinga
News headline image
ENGN Stock Soars On Hopeful Data From Bladder Cancer Study ↗
Via Stocktwits
News headline image
Get insights into the top gainers and losers of Tuesday's pre-market session. ↗
Via Chartmill
News headline image
Detalimogene Demonstrates Improved Complete Response Rate of 62% at 6 Months
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene to Participate in Upcoming Investor Conferences
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene Named a BioSpace 2026 Best Places to Work Winner
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene Appoints Hussein Sweiti, M.D., MSc, as Chief Medical Officer
From enGene Holdings Inc.
Via Business Wire
News headline image
enGene Holdings Inc (NASDAQ:ENGN) Posts Wider-Than-Expected Q3 Loss as R&D Spending Doubles ↗
Via Chartmill

Frequently Asked Questions

Is enGene Holdings Inc. - Common Stock publicly traded?
Yes, enGene Holdings Inc. - Common Stock is publicly traded.
What exchange does enGene Holdings Inc. - Common Stock trade on?
enGene Holdings Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for enGene Holdings Inc. - Common Stock?
The ticker symbol for enGene Holdings Inc. - Common Stock is ENGN on the Nasdaq Stock Market
What is the current price of enGene Holdings Inc. - Common Stock?
The current price of enGene Holdings Inc. - Common Stock is 9.370
When was enGene Holdings Inc. - Common Stock last traded?
The last trade of enGene Holdings Inc. - Common Stock was at 02/09/26 11:05 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.